{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:12:49Z","timestamp":1784664769340,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1245\/s10434-022-11836-2","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T13:06:01Z","timestamp":1651669561000},"page":"5861-5870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy"],"prefix":"10.1245","volume":"29","author":[{"given":"Yuki","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell G.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa M.","family":"Arvide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Gottumukkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wei D.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Badgwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"11836_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"11836_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"11836_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"S-E Al-Batran","year":"2019","unstructured":"Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. The Lancet. 2019;393:1948\u201357.","journal-title":"The Lancet"},{"key":"11836_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12885-015-1529-x","volume":"15","author":"T Leong","year":"2015","unstructured":"Leong T, Smithers BM, Michael M, Gebski V, Boussioutas A, Miller D, et al. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG\/TROG\/EORTC\/NCIC CTG). BMC Cancer. 2015;15:532.","journal-title":"BMC Cancer"},{"key":"11836_CR5","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, et al. PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39:2903\u201313.","journal-title":"J Clin Oncol"},{"key":"11836_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10120-018-00906-8","volume":"22","author":"I Uyama","year":"2019","unstructured":"Uyama I, Suda K, Nakauchi M, Kinoshita T, Noshiro H, Takiguchi S, et al. Clinical advantages of robotic gastrectomy for clinical stage I\/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer. 2019;22:377\u201385.","journal-title":"Gastric Cancer"},{"key":"11836_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10120-015-0501-4","volume":"18","author":"M Terashima","year":"2015","unstructured":"Terashima M, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Miki Y, et al. Robotic surgery for gastric cancer. Gastric Cancer. 2015;18:449\u201357.","journal-title":"Gastric Cancer"},{"key":"11836_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00384-017-2943-0","volume":"33","author":"R Tolstrup","year":"2018","unstructured":"Tolstrup R, Funder JA, Lundbech L, Thomassen N, Iversen LH. Perioperative pain after robot-assisted versus laparoscopic rectal resection. Int J Colorectal Dis. 2018;33:285\u20139.","journal-title":"Int J Colorectal Dis"},{"key":"11836_CR9","doi-asserted-by":"crossref","unstructured":"Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, Wiggers T, et al. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev:CD005200, 2014","DOI":"10.1002\/14651858.CD005200.pub3"},{"key":"11836_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ajog.2016.12.175","volume":"216","author":"E Blanton","year":"2017","unstructured":"Blanton E, Lamvu G, Patanwala I, Barron KI, Witzeman K, Tu FF, et al. Non-opioid pain management in benign minimally invasive hysterectomy: a systematic review. Am J Obstet Gynecol. 2017;216:557\u201367.","journal-title":"Am J Obstet Gynecol"},{"key":"11836_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00464-018-6477-5","volume":"33","author":"DS Keller","year":"2019","unstructured":"Keller DS, Zhang J, Chand M. Opioid-free colorectal surgery: a method to improve patient & financial outcomes in surgery. Surg Endosc. 2019;33:1959\u201366.","journal-title":"Surg Endosc"},{"key":"11836_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.surg.2019.05.012","volume":"166","author":"AW Knight","year":"2019","unstructured":"Knight AW, Habermann EB, Ubl DS, Zielinski MD, Thiels CA. Opioid utilization in minimally invasive versus open inguinal hernia repair. Surgery. 2019;166:752\u20137.","journal-title":"Surgery"},{"key":"11836_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.amjsurg.2019.11.030","volume":"220","author":"AL Bastawrous","year":"2020","unstructured":"Bastawrous AL, Shih IF, Li Y, Cleary RK. Minimally invasive sigmoidectomy for diverticular disease decreases inpatient opioid use: results of a propensity score-matched study. Am J Surg. 2020;220:421\u20137.","journal-title":"Am J Surg"},{"key":"11836_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jso.26591","volume":"124","author":"AN Blumenthaler","year":"2021","unstructured":"Blumenthaler AN, Robinson KA, Kruse BC, Munder K, Ikoma N, Mansfield PF, et al. Implementation of a perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer. J Surg Oncol. 2021;124:780\u201390.","journal-title":"J Surg Oncol"},{"key":"11836_CR15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","volume":"393","author":"LA Colvin","year":"2019","unstructured":"Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia\u2014when is enough too much? A review of opioid-induced tolerance and hyperalgesia. The Lancet. 2019;393:1558\u201368.","journal-title":"The Lancet"},{"key":"11836_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/SLA.0000000000003112","volume":"272","author":"TE Newhook","year":"2020","unstructured":"Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, et al. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg. 2020;272:163\u20139.","journal-title":"Ann Surg"},{"key":"11836_CR17","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/2019.1.FOCUS18645","volume":"46","author":"EM Soffin","year":"2019","unstructured":"Soffin EM, Wetmore DS, Beckman JD, Sheha ED, Vaishnav AS, Albert TJ, et al. Opioid-free anesthesia within an enhanced recovery after surgery pathway for minimally invasive lumbar spine surgery: a retrospective matched cohort study. Neurosurg Focus. 2019;46:E8.","journal-title":"Neurosurg Focus"},{"key":"11836_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ygyno.2020.01.041","volume":"157","author":"E Weston","year":"2020","unstructured":"Weston E, Noel M, Douglas K, Terrones K, Grumbine F, Stone R, et al. The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy. Gynecol Oncol. 2020;157:469\u201375.","journal-title":"Gynecol Oncol"},{"key":"11836_CR19","unstructured":"Kane S, Opioid (opiate) equianagesia conversion calculator, Mar 12, 2017."},{"key":"11836_CR20","unstructured":"American Pain Society, Principles of analgesic use in the treatment of acute pain and cancer pain. 6th ed., Glenview, IL, 2008"},{"key":"11836_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","volume":"22","author":"J Pereira","year":"2001","unstructured":"Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22:672\u201387.","journal-title":"J Pain Symptom Manage"},{"key":"11836_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0885-3924(01)00271-8","volume":"21","author":"R Anderson","year":"2001","unstructured":"Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manage. 2001;21:397\u2013406.","journal-title":"J Pain Symptom Manage"},{"key":"11836_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1345\/aph.1H421","volume":"41","author":"AE Patanwala","year":"2007","unstructured":"Patanwala AE, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother. 2007;41:255\u201366.","journal-title":"Ann Pharmacother"},{"key":"11836_CR24","unstructured":"Opioid Data Analysis and Resources, Centers for disease control and prevention, national center for injury prevention and control."},{"key":"11836_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241\u20138.","journal-title":"N Engl J Med"},{"key":"11836_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/SLA.0000000000003379","volume":"271","author":"B Davies","year":"2020","unstructured":"Davies B, Brummett CM. Anchoring to zero exposure: opioid-free minimally invasive surgery. Ann Surg. 2020;271:37\u20138.","journal-title":"Ann Surg"},{"key":"11836_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","volume":"58","author":"P Skolnick","year":"2018","unstructured":"Skolnick P. The opioid epidemic: crisis and solutions. Annu Rev Pharmacol Toxicol. 2018;58:143\u201359.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11836_CR28","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jama.2016.0130","volume":"315","author":"H Wunsch","year":"2016","unstructured":"Wunsch H, Wijeysundera DN, Passarella MA, Neuman MD. Opioids prescribed after low-risk surgical procedures in the United States, 2004\u20132012. JAMA. 2016;315:1654\u20137.","journal-title":"JAMA"},{"key":"11836_CR29","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","volume":"35","author":"JS Lee","year":"2017","unstructured":"Lee JS, Hu HM, Edelman AL, Brummett CM, Englesbe MJ, Waljee JF, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35:4042\u20139.","journal-title":"J Clin Oncol"},{"key":"11836_CR30","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1001\/jamaoncol.2018.4387","volume":"4","author":"S Tuminello","year":"2018","unstructured":"Tuminello S, Schwartz RM, Liu B, Mhango G, Wisnivesky J, Flores R, et al. Opioid use after open resection or video-assisted thoracoscopic surgery for early-stage lung cancer. JAMA Oncol. 2018;4:1611\u20133.","journal-title":"JAMA Oncol"},{"key":"11836_CR31","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1245\/s10434-019-07321-y","volume":"26","author":"HA Lillemoe","year":"2019","unstructured":"Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, et al. Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habits. Ann Surg Oncol. 2019;26:2011\u20138. https:\/\/doi.org\/10.1245\/s10434-019-07321-y.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jso.25983","volume":"122","author":"BJ Kim","year":"2020","unstructured":"Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, et al. Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol. 2020;122:547\u201354.","journal-title":"J Surg Oncol"},{"key":"11836_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1245\/s10434-019-07837-3","volume":"26","author":"HA Lillemoe","year":"2019","unstructured":"Lillemoe HA, Tzeng CD. ASO author reflections: opioid prescribing in surgical oncology-institutional opportunities for educational interventions. Ann Surg Oncol. 2019;26:731\u20132. https:\/\/doi.org\/10.1245\/s10434-019-07837-3.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/jso.26106","volume":"122","author":"HA Lillemoe","year":"2020","unstructured":"Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, et al. Perceptions of opioid use and prescribing habits in oncologic surgery: a survey of the society of surgical oncology membership. J Surg Oncol. 2020;122:1066\u201373.","journal-title":"J Surg Oncol"},{"key":"11836_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1245\/s10434-019-07876-w","volume":"26","author":"TE Newhook","year":"2019","unstructured":"Newhook TE, Tzeng CD. ASO author reflections: opportunities for reducing initial opioid exposure in cancer surgery patients. Ann Surg Oncol. 2019;26:749\u201350. https:\/\/doi.org\/10.1245\/s10434-019-07876-w.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR36","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1245\/s10434-019-07528-z","volume":"26","author":"TE Newhook","year":"2019","unstructured":"Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, et al. Inpatient opioid use after pancreatectomy: opportunities for reducing initial opioid exposure in cancer surgery patients. Ann Surg Oncol. 2019;26:3428\u201335. https:\/\/doi.org\/10.1245\/s10434-019-07528-z.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jamcollsurg.2017.10.012","volume":"226","author":"MV Hill","year":"2018","unstructured":"Hill MV, Stucke RS, Billmeier SE, Kelly JL, Barth RJ Jr. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg. 2018;226:996\u20131003.","journal-title":"J Am Coll Surg"},{"key":"11836_CR38","unstructured":"Anuj Shah CJH, Bradley CM, Characteristics of initial prescription episodes and likelihood of long-term opioid use \u2014 United States, 2006\u20132015."},{"key":"11836_CR39","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/jamasurg.2020.3527","volume":"155","author":"RW Day","year":"2020","unstructured":"Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, et al. Assessing the 5x-multiplier calculation to reduce discharge opioid prescription volumes after inpatient surgery. JAMA Surg. 2020;155:1166\u20137.","journal-title":"JAMA Surg"},{"key":"11836_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jso.26476","volume":"124","author":"BJ Kim","year":"2021","unstructured":"Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, et al. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. 2021;124:143\u201351.","journal-title":"J Surg Oncol"},{"key":"11836_CR41","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1245\/s10434-015-4381-y","volume":"22","author":"KJ Kelly","year":"2015","unstructured":"Kelly KJ, Selby L, Chou JF, Dukleska K, Capanu M, Coit DG, et al. Laparoscopic versus open gastrectomy for gastric adenocarcinoma in the West: a case-control study. Ann Surg Oncol. 2015;22:3590\u20136. https:\/\/doi.org\/10.1245\/s10434-015-4381-y.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s13304-020-00958-5","volume":"73","author":"YM Kim","year":"2021","unstructured":"Kim YM, Hyung WJ. Current status of robotic gastrectomy for gastric cancer: comparison with laparoscopic gastrectomy. Updates Surg. 2021;73:853\u201363.","journal-title":"Updates Surg"},{"key":"11836_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ags3.12438","volume":"5","author":"T Irino","year":"2021","unstructured":"Irino T, Matsuda S, Wada N, Kawakubo H, Kitagawa Y. Essential updates 2019\/2020: Perioperative and surgical management of gastric cancer. Ann Gastroenterol Surg. 2021;5:162\u201372.","journal-title":"Ann Gastroenterol Surg"},{"key":"11836_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S2468-1253(19)30332-2","volume":"5","author":"H Katai","year":"2020","unstructured":"Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5:142\u201351.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11836_CR45","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaoncol.2018.6727","volume":"5","author":"HH Kim","year":"2019","unstructured":"Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. 2019;5:506\u201313.","journal-title":"JAMA Oncol"},{"key":"11836_CR46","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1001\/jamaoncol.2020.3152","volume":"6","author":"F Liu","year":"2020","unstructured":"Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, et al. morbidity and mortality of laparoscopic vs open total gastrectomy for clinical stage I gastric cancer: the CLASS02 multicenter randomized clinical trial. JAMA Oncol. 2020;6:1590\u20137.","journal-title":"JAMA Oncol"},{"key":"11836_CR47","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s10120-018-0864-4","volume":"22","author":"WJ Hyung","year":"2019","unstructured":"Hyung WJ, Yang HK, Han SU, Lee YJ, Park JM, Kim JJ, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer. 2019;22:214\u201322.","journal-title":"Gastric Cancer"},{"key":"11836_CR48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10120-019-00929-9","volume":"22","author":"H Katai","year":"2019","unstructured":"Katai H, Mizusawa J, Katayama H, Kunisaki C, Sakuramoto S, Inaki N, et al. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan clinical oncology group study JCOG1401. Gastric Cancer. 2019;22:999\u20131008.","journal-title":"Gastric Cancer"},{"key":"11836_CR49","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1001\/jama.2019.5359","volume":"321","author":"J Yu","year":"2019","unstructured":"Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, et al. effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321:1983\u201392.","journal-title":"JAMA"},{"key":"11836_CR50","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/SLA.0000000000003217","volume":"270","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Hyung WJ, Yang HK, Han SU, Park YK, An JY, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg. 2019;270:983\u201391.","journal-title":"Ann Surg"},{"key":"11836_CR51","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1200\/JCO.20.01210","volume":"38","author":"WJ Hyung","year":"2020","unstructured":"Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, et al. long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol. 2020;38:3304\u201313.","journal-title":"J Clin Oncol"},{"key":"11836_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10120-020-01109-w","volume":"24","author":"N van der Wielen","year":"2021","unstructured":"van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J, et al. Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer. 2021;24:258\u201371.","journal-title":"Gastric Cancer"},{"key":"11836_CR53","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1200\/JCO.20.01540","volume":"39","author":"A van der Veen","year":"2021","unstructured":"van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol. 2021;39:978\u201389.","journal-title":"J Clin Oncol"},{"key":"11836_CR54","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s11605-021-04979-2","volume":"25","author":"N Ikoma","year":"2021","unstructured":"Ikoma N, Mansfield PF, Badgwell BD. Robotic D2 total gastrectomy with fluorescent lymphatic mapping for gastric cancer: effective use of the 4th arm. J Gastrointest Surg. 2021;25:1354\u20136.","journal-title":"J Gastrointest Surg"},{"key":"11836_CR55","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1245\/s10434-020-08523-5","volume":"27","author":"N Ikoma","year":"2020","unstructured":"Ikoma N, Badgwell BD, Mansfield P. Fluorescent-image guidance in robotic subtotal gastrectomy. Ann Surg Oncol. 2020;27:5322. https:\/\/doi.org\/10.1245\/s10434-020-08523-5.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR56","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s11605-021-04958-7","volume":"25","author":"N Ikoma","year":"2021","unstructured":"Ikoma N, Badgwell BD, Mansfield PF. Robotic proximal gastrectomy with double-tract reconstruction for gastroesophageal junction cancer. J Gastrointest Surg. 2021;25:1357\u20138.","journal-title":"J Gastrointest Surg"},{"key":"11836_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2021.06.234","author":"N Ikoma","year":"2021","unstructured":"Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, et al. Early experience of a robotic foregut surgery program at a cancer center: video of shared steps in robotic pancreatoduodenectomy and gastrectomy. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1016\/j.hpb.2021.06.234.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR58","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/den.12697","volume":"28","author":"K Suda","year":"2016","unstructured":"Suda K, Nakauchi M, Inaba K, Ishida Y, Uyama I. Robotic surgery for upper gastrointestinal cancer: current status and future perspectives. Dig Endosc. 2016;28:701\u201313.","journal-title":"Dig Endosc"},{"key":"11836_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1245\/s10434-020-08834-7","volume":"28","author":"VE Strong","year":"2021","unstructured":"Strong VE, Russo AE, Nakauchi M, Schattner M, Selby LV, Herrera G, et al. Robotic gastrectomy for gastric adenocarcinoma in the USA: insights and oncologic outcomes in 220 patients. Ann Surg Oncol. 2021;28:742\u201350. https:\/\/doi.org\/10.1245\/s10434-020-08834-7.","journal-title":"Ann Surg Oncol"},{"key":"11836_CR60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10120-019-00979-z","volume":"22","author":"GI van Boxel","year":"2019","unstructured":"van Boxel GI, Ruurda JP, van Hillegersberg R. Robotic-assisted gastrectomy for gastric cancer: a European perspective. Gastric Cancer. 2019;22:909\u201319.","journal-title":"Gastric Cancer"},{"key":"11836_CR61","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1097\/AIA.0000000000000113","volume":"54","author":"BJ Kim","year":"2016","unstructured":"Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The impact of postoperative complications on a timely return to intended oncologic therapy (riot): the role of enhanced recovery in the cancer journey. Int Anesthesiol Clin. 2016;54:e33-46.","journal-title":"Int Anesthesiol Clin"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11836-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11836-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11836-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T18:03:33Z","timestamp":1659809013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11836-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11836"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11836-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"24 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NI received a research grant from Intuitive Surgical.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and regional) and with the Helsinki Declaration of 1975 as revised in 1983. Because this was a retrospective study of deidentified patients, no informed consent was required. Ethics approval for this work was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}